Screening for prostate cancer: U.S. preventive services task force recommendation statement

Ned Calonge, Diana B. Petitti, Thomas G. Dewitt, Allen J. Dietrich, Kimberly D. Gregory, Russell Harris, George J. Isham, Michael L. Lefevre, Roseanne Leipzig, Carol Loveland-Cherry, Lucy N. Marion, Bernadette Melnyk, Virginia A. Moyer, Judith K. Ockene, George F. Sawaya, Barbara P. Yawn

Research output: Contribution to journalReview articlepeer-review

498 Scopus citations


Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement about screening for prostate cancer. Methods: The USPSTF evaluated randomized, controlled trials of the benefits of prostate cancer screening; cohort and cross-sectional studies of the psychological harms of false-positive prostate-specific antigen test results; and evidence on the natural history of prostate-specific antigen-detected prostate cancer to address previously identified gaps in the evidence from the 2002 USPSTF recommendation. Recommendations: Current evidence is insufficient to assess the balance of benefits and harms of screening for prostate cancer in men younger than age 75 years (I statement). Do not screen for prostate cancer in men age 75 years or older (Grade D recommendation).

Original languageEnglish (US)
Pages (from-to)185-191
Number of pages7
JournalAnnals of internal medicine
Issue number3
StatePublished - Aug 5 2008
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Screening for prostate cancer: U.S. preventive services task force recommendation statement'. Together they form a unique fingerprint.

Cite this